WO2001064273A3 - Aerosol-doseur - Google Patents

Aerosol-doseur Download PDF

Info

Publication number
WO2001064273A3
WO2001064273A3 PCT/EP2001/002212 EP0102212W WO0164273A3 WO 2001064273 A3 WO2001064273 A3 WO 2001064273A3 EP 0102212 W EP0102212 W EP 0102212W WO 0164273 A3 WO0164273 A3 WO 0164273A3
Authority
WO
WIPO (PCT)
Prior art keywords
metered dose
dose inhaler
therapy
conductivity
degrees
Prior art date
Application number
PCT/EP2001/002212
Other languages
English (en)
Other versions
WO2001064273A2 (fr
Inventor
Mark Andrew Hailey
Original Assignee
Glaxo Group Ltd
Mark Andrew Hailey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0004761A external-priority patent/GB0004761D0/en
Priority claimed from GB0018653A external-priority patent/GB0018653D0/en
Priority claimed from GB0018624A external-priority patent/GB0018624D0/en
Application filed by Glaxo Group Ltd, Mark Andrew Hailey filed Critical Glaxo Group Ltd
Priority to AU44170/01A priority Critical patent/AU4417001A/en
Priority to US10/220,486 priority patent/US20030150447A1/en
Priority to EP01917037A priority patent/EP1259276A2/fr
Priority to JP2001563169A priority patent/JP2003525089A/ja
Publication of WO2001064273A2 publication Critical patent/WO2001064273A2/fr
Publication of WO2001064273A3 publication Critical patent/WO2001064273A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)

Abstract

La présente invention concerne un aérosol-doseur qui comprend une surface interface possédant les propriétés suivantes: i) un angle de contact supérieur à 70 degrés, et ii) une conductivité supérieure à 2,4 mS. Cette invention concerne aussi des processus de préparation et d'utilisation thérapeutique de celui-ci.
PCT/EP2001/002212 2000-03-01 2001-02-28 Aerosol-doseur WO2001064273A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU44170/01A AU4417001A (en) 2000-03-01 2001-02-28 Metered dose inhaler
US10/220,486 US20030150447A1 (en) 2000-03-01 2001-02-28 Metered dose inhaler
EP01917037A EP1259276A2 (fr) 2000-03-01 2001-02-28 Aerosol-doseur
JP2001563169A JP2003525089A (ja) 2000-03-01 2001-02-28 定量噴霧式吸入器

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0004761.3 2000-03-01
GB0004761A GB0004761D0 (en) 2000-03-01 2000-03-01 Metered dose inhaler
GB0018653A GB0018653D0 (en) 2000-07-28 2000-07-28 Metered dose inhaler
GB0018624A GB0018624D0 (en) 2000-07-28 2000-07-28 Metered dose inhaler
GB0018624.7 2000-07-28
GB0018653.6 2000-07-28

Publications (2)

Publication Number Publication Date
WO2001064273A2 WO2001064273A2 (fr) 2001-09-07
WO2001064273A3 true WO2001064273A3 (fr) 2002-03-28

Family

ID=27255564

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/002212 WO2001064273A2 (fr) 2000-03-01 2001-02-28 Aerosol-doseur

Country Status (4)

Country Link
EP (1) EP1259276A2 (fr)
JP (1) JP2003525089A (fr)
AU (1) AU4417001A (fr)
WO (1) WO2001064273A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
GB0721737D0 (en) 2007-11-06 2007-12-19 3M Innovative Properties Co Medicinal inhalation devices and components thereof
GB0721739D0 (en) 2007-11-06 2007-12-19 3M Innovative Properties Co medicinal inhalation devices and components thereof
AU2008323924B2 (en) 2007-11-06 2013-01-17 3M Innovative Properties Company Medicinal inhalation devices and components thereof
US20120097159A1 (en) 2009-05-06 2012-04-26 Suresh Iyer Medicinal inhalation devices and components thereof
US8815325B2 (en) 2009-05-06 2014-08-26 3M Innovative Properties Company Medicinal inhalation device
CN102460635B (zh) 2009-05-06 2014-12-24 3M创新有限公司 对容器进行等离子体处理的装置和方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0622353A2 (fr) * 1993-04-28 1994-11-02 AUSIMONT S.p.A. Revêtements à base de perfluorpolyéthers contenant des groupes acryliques
WO1996032345A1 (fr) * 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Inhalateur doseur de dipropionate de beclomethasone
WO1998019727A1 (fr) * 1996-11-01 1998-05-14 E.I. Du Pont De Nemours And Company Tube rallonge pour aerosols-doseurs empechant l'accumulation
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0622353A2 (fr) * 1993-04-28 1994-11-02 AUSIMONT S.p.A. Revêtements à base de perfluorpolyéthers contenant des groupes acryliques
WO1996032345A1 (fr) * 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Inhalateur doseur de dipropionate de beclomethasone
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
WO1998019727A1 (fr) * 1996-11-01 1998-05-14 E.I. Du Pont De Nemours And Company Tube rallonge pour aerosols-doseurs empechant l'accumulation

Also Published As

Publication number Publication date
WO2001064273A2 (fr) 2001-09-07
AU4417001A (en) 2001-09-12
EP1259276A2 (fr) 2002-11-27
JP2003525089A (ja) 2003-08-26

Similar Documents

Publication Publication Date Title
MY131803A (en) Aerosolized active agent delivery
WO2002032414A3 (fr) Polytherapie a base de ribavirine et d'interferon alpha pegyle contre le virus de l'hepatite c
NO983555L (no) Ny formulering
CA2278552A1 (fr) Inhalateur a dose unique ii
WO1999043355A3 (fr) Formulations
GB2365772A (en) Factor
CA2334267A1 (fr) Utilisation de peg-ifn-alpha et de ribavirine pour traiter l'hepatite c chronique
HK1030157A1 (en) Use of consensus interferon and compositions comprising consensus interferon.
HUP0101507A3 (en) Formulation for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulation into mucosal cavities
WO2002004421A3 (fr) Analogues de pyridoxine et de pyridoxal utilises comme agents de therapie cardio-vasculaire
WO2003045332A3 (fr) Methodes et compositions permettant de traiter des lesions de l'epithelium respiratoire
CA2373794A1 (fr) Compositions et utilisation d'et743 pour le traitement du cancer
WO2001064273A3 (fr) Aerosol-doseur
AU2001289606A1 (en) Dry powder formulation comprising racecadotril
AU2001287850A1 (en) Iron compositions
CA2433833A1 (fr) Utilisation de flumazenil dans l'elaboration d'un medicament visant a traiter la dependence a l'alcool
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
WO2000001415A3 (fr) Utilisation d'inhibiteurs de la proteine kinase c epsilon dans le traitement de la douleur
WO2001064524A3 (fr) Inhalateur-doseur
WO2001064274A3 (fr) Aerosol-doseur
EP1051964A3 (fr) Composition cosmétique de gommage
BR0115983A (pt) Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
MXPA02008870A (es) Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos.
AUPQ866500A0 (en) Therapeutic compounds and methods

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 563169

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001917037

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001917037

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10220486

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001917037

Country of ref document: EP